Masoud Toloue, Quanterix CEO

Quan­ter­ix clos­es Akoya deal af­ter com­pet­ing bid

Quan­ter­ix has com­plet­ed its ac­qui­si­tion of Akoya Bio­sciences, fol­low­ing in­ter­est from a third-par­ty bid­der who threat­ened to tor­pe­do the deal that has a to­tal en­ter­prise …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.